Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Apple
AAPL
|
+$2.94B |
| 2 |
Amazon
AMZN
|
+$1.22B |
| 3 |
NVIDIA
NVDA
|
+$1.11B |
| 4 |
Microsoft
MSFT
|
+$1.01B |
| 5 |
Procter & Gamble
PG
|
+$784M |
Top Sells
| 1 |
Qualcomm
QCOM
|
+$619M |
| 2 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$582M |
| 3 |
Phillips 66
PSX
|
+$575M |
| 4 |
Eli Lilly
LLY
|
+$377M |
| 5 |
HES
Hess
HES
|
+$326M |
Sector Composition
| 1 | Technology | 31.4% |
| 2 | Financials | 12.71% |
| 3 | Consumer Discretionary | 10.47% |
| 4 | Healthcare | 9.99% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIO
3326
City Office REIT
CIO
$280M
| $155K | ﹤0.01% |
29,679
-24,468
| -45% | -$128K |
|
3327
Lexicon Pharmaceuticals
LXRX
$392M
| $155K | ﹤0.01% |
64,619
-62,397
| -49% | -$150K |
|
3328
Zegna
ZGN
$2.26B
| $155K | ﹤0.01% |
10,548
| – | – |
|
3329
EverCommerce
EVCM
$2.06B
| $154K | ﹤0.01% |
16,353
-15,701
| -49% | -$148K |
|
3330
Monte Rosa Therapeutics
GLUE
$296M
| $154K | ﹤0.01% |
21,748
-39,520
| -65% | -$280K |
|
3331
Intrepid Potash
IPI
$392M
| $154K | ﹤0.01% |
7,381
-7,142
| -49% | -$149K |
|
|
SII
3332
Sprott
SII
$1.78B
| $154K | ﹤0.01% |
4,158
-123
| -3% | -$4.56K |
|
3333
Acrivon Therapeutics
ACRV
$51.3M
| $153K | ﹤0.01% |
21,324
-3,160
| -13% | -$22.7K |
|
3334
Urban One Class A
UONE
$65.3M
| $153K | ﹤0.01% |
56,831
-105,684
| -65% | -$285K |
|
3335
Actinium Pharmaceuticals
ATNM
$50.2M
| $152K | ﹤0.01% |
19,369
-18,347
| -49% | -$144K |
|
3336
Generation Bio
GBIO
$40.3M
| $152K | ﹤0.01% |
3,741
-3,045
| -45% | -$124K |
|
|
THRD
3337
DELISTED
Third Harmonic Bio
THRD
| $152K | ﹤0.01% |
16,032
-10,704
| -40% | -$101K |
|
3338
ProFrac Holding
ACDC
$695M
| $151K | ﹤0.01% |
18,062
-17,520
| -49% | -$146K |
|
3339
FibroGen
FGEN
$46.5M
| $151K | ﹤0.01% |
2,579
-6,838
| -73% | -$400K |
|
3340
Inspired Entertainment
INSE
$250M
| $151K | ﹤0.01% |
15,293
-14,552
| -49% | -$144K |
|
3341
Provident Bancorp
PVBC
$226M
| $151K | ﹤0.01% |
16,591
-7,474
| -31% | -$68K |
|
3342
Mammoth Energy Services
TUSK
$113M
| $151K | ﹤0.01% |
41,423
-16,304
| -28% | -$59.4K |
|
|
ITI
3343
DELISTED
Iteris, Inc.
ITI
| $151K | ﹤0.01% |
30,523
-28,454
| -48% | -$141K |
|
3344
Cambium Networks
CMBM
$19.8M
| $150K | ﹤0.01% |
34,777
-8,157
| -19% | -$35.2K |
|
3345
Compass Therapeutics
CMPX
$604M
| $150K | ﹤0.01% |
75,913
-49,573
| -40% | -$98K |
|
3346
Commercial Vehicle Group
CVGI
$70.3M
| $150K | ﹤0.01% |
23,325
-22,508
| -49% | -$145K |
|
3347
Future Fuel
FF
$171M
| $150K | ﹤0.01% |
18,624
-16,706
| -47% | -$135K |
|
3348
NextCure
NXTC
$14.7M
| $150K | ﹤0.01% |
5,629
| – | – |
|
3349
American Coastal Insurance
ACIC
$526M
| $149K | ﹤0.01% |
13,984
-12,944
| -48% | -$138K |
|
3350
Sangamo Therapeutics
SGMO
$160M
| $149K | ﹤0.01% |
222,055
-102,332
| -32% | -$68.7K |
|